CytomX Therapeutics Inc (CTMX)
1.62
+0.02
(+1.25%)
USD |
NASDAQ |
Apr 26, 15:26
CytomX Therapeutics Shareholders Equity (Quarterly): -47.45M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -47.45M |
| September 30, 2023 | -51.24M |
| June 30, 2023 | -85.03M |
| March 31, 2023 | -86.64M |
| December 31, 2022 | -85.75M |
| September 30, 2022 | 28.47M |
| June 30, 2022 | 48.71M |
| March 31, 2022 | 68.19M |
| December 31, 2021 | -0.459M |
| September 30, 2021 | 111.67M |
| June 30, 2021 | 130.95M |
| March 31, 2021 | 146.02M |
| December 31, 2020 | -7.774M |
| September 30, 2020 | 48.06M |
| June 30, 2020 | 58.83M |
| March 31, 2020 | 69.77M |
| December 31, 2019 | 51.11M |
| September 30, 2019 | 82.11M |
| Date | Value |
|---|---|
| June 30, 2019 | 101.50M |
| March 31, 2019 | 122.57M |
| December 31, 2018 | 130.88M |
| September 30, 2018 | 157.66M |
| June 30, 2018 | 41.13M |
| March 31, 2018 | 49.65M |
| December 31, 2017 | 69.90M |
| September 30, 2017 | 45.48M |
| June 30, 2017 | 52.24M |
| March 31, 2017 | 73.79M |
| December 31, 2016 | 78.48M |
| September 30, 2016 | 89.42M |
| June 30, 2016 | 101.19M |
| March 31, 2016 | 112.71M |
| December 31, 2015 | 126.07M |
| September 30, 2015 | -106.05M |
| June 30, 2015 | 63.60M |
| December 31, 2014 | -78.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-86.64M
Minimum
Mar 2023
146.02M
Maximum
Mar 2021
30.58M
Average
48.71M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 25.97B |
| Sarepta Therapeutics Inc | 859.34M |
| Puma Biotechnology Inc | 53.44M |
| Ocular Therapeutix Inc | 91.13M |
| Bristol-Myers Squibb Co | 29.43B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 201.79M |
| Total Liabilities (Quarterly) | 249.24M |
| Current Ratio | 1.173 |